---
schema_version: "secwatch.filing_event.v1"
accession: "0001006837-24-000121"
form_type: "8-K"
ticker: "VATE"
cik: "0001006837"
company_name: "INNOVATE Corp."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:32:40.559731+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INNOVATE Q2 net income $14.1M vs loss $10.5M YoY; revenue $313M (-15%), adj. EBITDA $26.7M

## Summary
- Revenue $313.1M (-15.1% YoY); net income $14.1M vs loss $10.5M; diluted EPS $0.10 vs ($0.13).
- Infrastructure: DBM Global revenue $305.2M (-15.8%) but net income $21.0M (vs $7.0M); adj. EBITDA $32.5M; gross margin expanded 650 bps to 20.2%.
- Life Sciences: R2 Glacial system record North America sales, 200% increase YoY; MediBeacon continues FDA kidney monitoring review.
- Spectrum: Broadcasting revenue $6.2M (+8.8%), adj. EBITDA $1.5M (vs $0.8M); launched third network Defy.
- Board approved 1-for-10 reverse stock split, effective August 9, 2024.

## SEC filing metadata
- accession: 0001006837-24-000121
- form_type: 8-K
- ticker: VATE
- cik: 0001006837
- company_name: INNOVATE Corp.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006837/000100683724000121/0001006837-24-000121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006837/000100683724000121/hchc-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001006837-24-000121
- JSON: https://secwatch.observer/filing/0001006837-24-000121.json
- Plain text: https://secwatch.observer/filing/0001006837-24-000121.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.